A GLP-2 drug candidate from Zealand Pharma failed to garner FDA approval as the regulatory agency asked for an additional trial to confirm the medication’s efficacy and safety.
Category: Becker’s Hospital Review
Hospitals can scale back hand hygiene monitoring: 4 study notes
Some evidence shows hospital infection preventionists may be able to spend less time monitoring hand hygiene, according to a study published Dec. 19 in the American Journal of Infection Control.
Health system IT leaders prep for 'future-ready healthcare systems'
Hospitals and health systems experimented with artificial intelligence last year and see 2025 as a crucial turning point for identifying top use cases and solidifying long-term strategies.
Bon Secours Mercy Health's next digital ventures move
Cincinnati-based Bon Secours Mercy Health launched Accrete Health Partners in 2022 as a holding company to align digital health teams as well as invest in and scale digital products.
Bon Secours Mercy Health's next digital ventures move
Cincinnati-based Bon Secours Mercy Health launched Accrete Health Partners in 2022 as a holding company to align digital health teams as well as invest in and scale digital products.
Physicians debate the need for weigh-ins
As some physicians decide to forgo routinely checking patient weight, others still consider weigh-ins a vital part of patient care, according to a Dec. 26 report from The New York Times.
Physicians debate the need for weigh-ins
As some physicians decide to forgo routinely checking patient weight, others still consider weigh-ins a vital part of patient care, according to a Dec. 26 report from The New York Times.
Florida hospital taps CFO
Lin Lin has been named CFO of Orlando (Fla.) Health St. Cloud Hospital.
Florida hospital taps CFO
Lin Lin has been named CFO of Orlando (Fla.) Health St. Cloud Hospital.
The GLP-1 dilemma persists into 2025
Insurers and self-funded employers are making significant changes to their GLP-1 drug coverage policies in 2025, reflecting the financial and operational challenges posed by the high-cost medications.
